×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

CytomX Therapeutics Inc. (CTMX) NASDAQ

$1.73 (0.03) (-1.70%)

Market Cap: $119.21M

As of 04/18/24 04:00 PM EDT. Market closed.

(CTMX)

CytomX Therapeutics Inc. (CTMX)
NASDAQ

$1.73
(0.03) (-1.70%)

Market Cap: $119.21M

As of 04/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

cytomx is an oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its probody technology platform. the company uses the platform to create development-stage proprietary cancer immunotherapies against clinically-validated targets, as well as to develop first-in-class investigational cancer therapeutics against novel targets. cytomx ... read more

cytomx is an oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its probody technology platform. the company uses the platform to create development-stage proprietary cancer immunotherapies against clinically-validated targets, as well as to develop first-in-class investigational cancer therapeutics against novel targets. cytomx believes that its probody platform has the potential to improve the combined efficacy and safety profile of monoclonal antibody modalities, including cancer immunotherapies, antibody drug conjugates and t-cell-recruiting bispecific antibodies. probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. investigational probody therapeutics are being developed that address clinically-validated cancer targets in immuno-oncology, such as pd-l1 against which o read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sean McCarthy
Full Time Employees
157
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$5.48M
URL
Address
151 Oyster Point Blvd Ste 400, California, South San Francisco, 94080-1910.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sean McCarthy
Full Time Employees
157
CEO Compensation (Base)
$550,000
CEO Compensation (Total)
$5.48M
Address
151 Oyster Point Blvd Ste 400, California, South San Francisco, 94080-1910.
PRICE CHART FOR CYTOMX THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.77
Previous Close
$1.76
Days Range
$1.72 - $1.79
52 week range
$1.04 - $2.86
Volume
198,849
Avg. Volume (30 days)
716,291
Market Cap
$119.21M
Dividend Yield
-
P/E
(209.50)
Shares Outstanding
67,731,764
Open
$1.77
Previous Close
$1.76
Days Range
$1.72 - $1.79
52 week range
$1.04 - $2.86
Volume
198,849
Avg. Volume (30 days)
716,291
Market Cap
$119.21M
Dividend Yield
-
P/E
(209.50)
Shares Outstanding
67,731,764
FINANCIAL STATEMENTS FOR CYTOMX THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CYTOMX THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
McCarthy Sean A.CEOMar 26, 2024 Option Exercise$1.57109,768172,874634,249Mar 28, 2024, 07:12 PM
ROWLAND LLOYD AGeneral CounselMar 19, 2024 Sale$2.095,26810,986117,728Mar 21, 2024, 04:41 PM
McCarthy Sean A.CEOMar 19, 2024 Sale$2.0920,22342,175524,481Mar 21, 2024, 04:40 PM
Ogden ChristopherSVP, Finance and AccountingMar 19, 2024 Sale$2.092,9716,19685,686Mar 21, 2024, 04:38 PM
BELVIN MARCIASVP, Chief Scientific OfficerMar 19, 2024 Sale$2.0912,79526,684168,579Mar 21, 2024, 04:37 PM
Landau Jeffrey BChief Business OfficerMar 19, 2024 Sale$2.096,56213,685110,060Mar 21, 2024, 04:36 PM
McCarthy Sean A.CEODec 20, 2023 Sale$1.3813,55118,710454,704Dec 22, 2023, 04:16 PM
BELVIN MARCIASVP, Chief Scientific OfficerDec 20, 2023 Sale$1.384,0775,628155,124Dec 22, 2023, 04:14 PM
Landau Jeffrey BChief Business OfficerDec 20, 2023 Sale$1.384,0775,62886,622Dec 22, 2023, 04:12 PM
ROWLAND LLOYD AGeneral CounselDec 20, 2023 Sale$1.384,0775,62997,996Dec 22, 2023, 04:11 PM
Ogden ChristopherSVP, Finance and AccountingDec 20, 2023 Sale$1.381,9902,74748,657Dec 22, 2023, 04:10 PM
BELVIN MARCIASVP, Chief Scientific OfficerSep 22, 2023 Sale$1.304,1195,356147,951Sep 22, 2023, 07:16 PM
Landau Jeffrey BChief Business OfficerSep 22, 2023 Sale$1.304,1195,35676,379Sep 22, 2023, 07:15 PM
McCarthy Sean A.CEOSep 22, 2023 Sale$1.3014,60118,987430,755Sep 22, 2023, 07:13 PM
ROWLAND LLOYD AGeneral CounselSep 22, 2023 Sale$1.305,4867,13580,609Sep 22, 2023, 07:12 PM
McCarthy Sean A.CEOMay 19, 2023 Option Exercise$1.5716,53526,041405,356May 23, 2023, 04:52 PM
Jones Elaine VDirectorMar 29, 2023 Buy$1.555,0007,7505,142Mar 31, 2023, 07:56 PM
Ogden ChristopherSVP, Finance and AccountingMar 16, 2023 Sale$1.985161,02137,772Mar 20, 2023, 06:43 PM
McCarthy Sean A.CEOMar 16, 2023 Sale$1.887,12113,391388,821Mar 20, 2023, 06:43 PM
Campoy CarlosChief Financial OfficerMar 16, 2023 Sale$1.981,7483,45938,224Mar 20, 2023, 06:43 PM
ROWLAND LLOYD AGeneral CounselMar 16, 2023 Sale$1.982,0374,03171,095Mar 20, 2023, 06:43 PM
Landau Jeffrey BChief Financial OfficerMar 16, 2023 Sale$1.981,4772,92369,248Mar 20, 2023, 06:43 PM
Peterson Amy C.EVP, Chief Development OfficerMar 16, 2023 Sale$1.984,2578,42558,433Mar 20, 2023, 06:43 PM
Peterson Amy C.EVP, Chief Development OfficerJul 20, 2022 Sale$1.427,46310,61262,690Jul 21, 2022, 04:11 PM
Landau Jeffrey BChief Business OfficerJul 20, 2022 Sale$1.424,2065,98230,725Jul 21, 2022, 04:11 PM
McCarthy Sean A.President and CEOJul 20, 2022 Sale$1.4214,91121,206290,942Jul 21, 2022, 04:10 PM
ROWLAND LLOYD AGeneral CounselJul 20, 2022 Sale$1.425,6027,96843,689Jul 21, 2022, 04:10 PM
HANNAH ALISON L.Chief Medical OfficerJul 20, 2022 Sale$1.425,6027,96531,898Jul 21, 2022, 04:09 PM
Campoy CarlosChief Financial OfficerJul 20, 2022 Sale$1.423,9495,61739,972Jul 21, 2022, 04:08 PM
McCarthy Sean A.President and CEOMay 09, 2022 Option Exercise$0.9490,93185,930265,853May 11, 2022, 04:51 PM
McCarthy Sean A.President and CEOAug 11, 2021 Option Exercise$1.1392,113104,44799,922Aug 13, 2021, 05:22 PM
McCarthy Sean A.President and CEOJun 14, 2021 Option Exercise$1.0940437,849Jun 16, 2021, 09:49 PM
Campoy CarlosChief Financial OfficerMay 31, 2021 Option Exercise$6.093,32020,2066,421Jun 08, 2021, 01:08 PM
Peterson Amy C.EVP, Chief Development OfficerMay 31, 2021 Option Exercise$6.093,32020,2066,421Jun 08, 2021, 01:07 PM
McCarthy Sean A.President and CEODec 23, 2020 Option Exercise$1.13100,000113,390206,894Dec 28, 2020, 07:52 PM
Peterson Amy C.EVP, Chief Development OfficerNov 30, 2020 Option Exercise$6.393,10119,8223,101Dec 07, 2020, 04:59 PM
McCarthy Sean A.President and CEONov 30, 2020 Option Exercise$6.399305,945106,894Dec 07, 2020, 04:58 PM
Campoy CarlosChief Financial OfficerNov 30, 2020 Option Exercise$6.393,10119,8223,101Dec 07, 2020, 04:57 PM
McCarthy Sean A.President and CEOSep 21, 2020 Option Exercise$6.6120,500135,601105,964Sep 23, 2020, 04:53 PM
McCarthy Sean A.President and CEOMay 29, 2020 Option Exercise$5.111,1585,91685,464Jun 02, 2020, 04:54 PM
McCarthy Sean A.President and CEOMay 12, 2020 Option Exercise$1.1336,00040,820120,306May 14, 2020, 04:31 PM
McCarthy Sean A.President and CEOMay 12, 2020 Sale$15.0036,000540,00084,306May 14, 2020, 04:31 PM
McCarthy Sean A.President and CEONov 30, 2019 Option Exercise$5.321,0805,74784,306Dec 16, 2019, 04:20 PM
ROWLAND LLOYD AGeneral CounselMay 31, 2019 Option Exercise$8.211,81214,87811,791Jun 04, 2019, 04:08 PM
Knifsend RobinPrincipal Accounting OfficerMay 31, 2019 Option Exercise$8.211,81214,8782,791Jun 04, 2019, 04:06 PM
McCarthy Sean A.President and CEOMay 31, 2019 Option Exercise$8.216955,70783,226Jun 04, 2019, 04:04 PM
ROWLAND LLOYD AGeneral CounselMar 04, 2019 Buy$10.339,00092,9709,979Mar 05, 2019, 12:00 AM
RAY DEBANJANChief Financial OfficerDec 12, 2018 Option Exercise$1.453,0004,3478,928Dec 14, 2018, 03:23 PM
RAY DEBANJANChief Financial OfficerDec 12, 2018 Sale$15.003,00045,0005,928Dec 14, 2018, 03:23 PM
McCarthy Sean A.President and CEONov 30, 2018 Option Exercise$11.734685,49082,531Dec 06, 2018, 01:57 PM
ROWLAND LLOYD AGeneral CounselNov 30, 2018 Option Exercise$11.7397911,484979Dec 06, 2018, 01:55 PM
RAY DEBANJANChief Financial OfficerNov 01, 2018 Option Exercise$1.453,0004,3478,928Nov 05, 2018, 04:15 PM
RAY DEBANJANChief Financial OfficerNov 01, 2018 Sale$15.003,00045,0005,928Nov 05, 2018, 04:15 PM
McCarthy Sean A.President and CEONov 02, 2018 Option Exercise$1.571,1561,82183,219Nov 05, 2018, 04:14 PM
McCarthy Sean A.President and CEONov 01, 2018 Option Exercise$1.575,3708,45787,433Nov 05, 2018, 04:14 PM
McCarthy Sean A.President and CEONov 02, 2018 Sale$15.011,15617,34882,063Nov 05, 2018, 04:14 PM
McCarthy Sean A.President and CEONov 01, 2018 Sale$15.005,37080,55187,333Nov 05, 2018, 04:14 PM
RAY DEBANJANChief Financial OfficerOct 01, 2018 Option Exercise$1.453,0004,3478,928Oct 02, 2018, 03:18 PM
RAY DEBANJANChief Financial OfficerOct 01, 2018 Sale$18.463,00055,3805,928Oct 02, 2018, 03:18 PM
RAY DEBANJANChief Financial OfficerSep 04, 2018 Option Exercise$1.453,0004,3478,928Sep 06, 2018, 07:18 PM
RAY DEBANJANChief Financial OfficerSep 04, 2018 Sale$22.393,00067,1705,928Sep 06, 2018, 07:18 PM
McCarthy Sean A.President and CEOSep 04, 2018 Option Exercise$1.5713,05220,55695,115Sep 06, 2018, 07:14 PM
McCarthy Sean A.President and CEOSep 04, 2018 Sale$21.8613,052285,34382,063Sep 06, 2018, 07:14 PM
RAY DEBANJANChief Financial OfficerAug 01, 2018 Option Exercise$1.283,0003,8358,928Aug 02, 2018, 08:55 PM
RAY DEBANJANChief Financial OfficerAug 01, 2018 Sale$26.053,00078,1505,928Aug 02, 2018, 08:55 PM
McCarthy Sean A.President and CEOJul 05, 2018 Option Exercise$1.574,4977,08286,560Jul 09, 2018, 06:15 PM
McCarthy Sean A.President and CEOJul 05, 2018 Sale$25.064,497112,68982,063Jul 09, 2018, 06:15 PM
McCarthy Sean A.President and CEOJul 03, 2018 Option Exercise$1.572,0283,19484,091Jul 06, 2018, 06:52 PM
McCarthy Sean A.President and CEOJul 03, 2018 Sale$25.092,02850,88082,063Jul 06, 2018, 06:52 PM
RAY DEBANJANChief Financial OfficerJul 02, 2018 Option Exercise$1.263,0003,7808,928Jul 03, 2018, 06:51 PM
RAY DEBANJANChief Financial OfficerJul 02, 2018 Sale$22.563,00067,6805,928Jul 03, 2018, 06:51 PM
McCarthy Sean A.President and CEOJul 02, 2018 Option Exercise$1.5713,05220,55695,115Jul 03, 2018, 06:50 PM
McCarthy Sean A.President and CEOJul 02, 2018 Sale$23.4213,052305,70882,063Jul 03, 2018, 06:50 PM
RAY DEBANJANChief Financial OfficerMay 31, 2018 Option Exercise$17.901,18721,2485,928Jun 05, 2018, 07:46 PM
RAY DEBANJANChief Financial OfficerJun 01, 2018 Option Exercise$1.263,0003,7808,928Jun 05, 2018, 07:46 PM
RAY DEBANJANChief Financial OfficerJun 01, 2018 Sale$25.933,00077,7935,928Jun 05, 2018, 07:46 PM
McCarthy Sean A.President and CEOMay 31, 2018 Option Exercise$17.903025,4064,945Jun 05, 2018, 07:45 PM
RAY DEBANJANChief Financial OfficerMay 01, 2018 Option Exercise$1.263,0003,7807,741May 02, 2018, 06:26 PM
RAY DEBANJANChief Financial OfficerMay 01, 2018 Sale$26.523,00079,5624,741May 02, 2018, 06:26 PM
McCarthy Sean A.President and CEOMay 01, 2018 Option Exercise$1.5719,57830,83324,221May 02, 2018, 06:25 PM
McCarthy Sean A.President and CEOMay 01, 2018 Sale$26.5519,578519,7434,643May 02, 2018, 06:25 PM
RAY DEBANJANChief Financial OfficerApr 02, 2018 Option Exercise$1.263,0003,7807,741Apr 04, 2018, 02:27 PM
RAY DEBANJANChief Financial OfficerApr 02, 2018 Sale$28.123,00084,3604,741Apr 04, 2018, 02:27 PM
GLUCK FREDERICK WDirectorMar 26, 2018 Sale$31.935,000159,642271,643Mar 27, 2018, 08:54 PM
GLUCK FREDERICK WDirectorMar 02, 2018 Sale$30.0016,181485,466276,643Mar 05, 2018, 07:01 PM
HUMPHREY RACHELChief Medical OfficerMar 02, 2018 Option Exercise$6.6116,160106,89446,394Mar 05, 2018, 06:59 PM
HUMPHREY RACHELChief Medical OfficerMar 02, 2018 Sale$30.0016,160484,80030,234Mar 05, 2018, 06:59 PM
McCarthy Sean A.President and CEOMar 01, 2018 Option Exercise$1.3719,57826,82524,221Mar 05, 2018, 12:00 AM
RAY DEBANJANChief Financial OfficerMar 02, 2018 Option Exercise$1.1720,00023,37319,226Mar 05, 2018, 12:00 AM
RAY DEBANJANChief Financial OfficerMar 01, 2018 Option Exercise$1.2613,00016,37917,741Mar 05, 2018, 12:00 AM
McCarthy Sean A.President and CEOMar 01, 2018 Sale$29.4319,578576,1414,643Mar 05, 2018, 12:00 AM
RAY DEBANJANChief Financial OfficerMar 02, 2018 Sale$30.3720,000607,4536,685Mar 05, 2018, 12:00 AM
RAY DEBANJANChief Financial OfficerMar 01, 2018 Sale$29.4013,000382,2424,741Mar 05, 2018, 12:00 AM
HUMPHREY RACHELChief Medical OfficerFeb 28, 2018 Option Exercise$6.6123,840157,69454,074Mar 02, 2018, 11:55 AM
HUMPHREY RACHELChief Medical OfficerFeb 28, 2018 Sale$30.0023,840715,20030,234Mar 02, 2018, 11:55 AM
GLUCK FREDERICK WDirectorFeb 28, 2018 Sale$30.003,819114,570292,824Mar 02, 2018, 11:54 AM
RAY DEBANJANChief Financial OfficerFeb 01, 2018 Sale$26.692,54868,0104,741Feb 02, 2018, 07:28 PM
McCarthy Sean A.President and CEOJan 05, 2018 Option Exercise$1.136,5267,40011,169Jan 09, 2018, 11:20 AM
McCarthy Sean A.President and CEOJan 05, 2018 Sale$25.016,526163,2154,643Jan 09, 2018, 11:20 AM
GLUCK FREDERICK WDirectorJan 05, 2018 Sale$25.0110,000250,078296,643Jan 08, 2018, 05:47 PM
McCarthy Sean A.President and CEOJan 02, 2018 Option Exercise$1.1313,05214,80017,695Jan 04, 2018, 12:25 PM
McCarthy Sean A.President and CEOJan 02, 2018 Sale$21.0413,052274,6144,643Jan 04, 2018, 12:25 PM
RAY DEBANJANChief Financial OfficerJan 02, 2018 Sale$21.112,50052,7757,289Jan 03, 2018, 03:23 PM
GLUCK FREDERICK WDirectorDec 26, 2017 Sale$22.295,000111,426306,643Dec 28, 2017, 05:56 PM
HUMPHREY RACHELChief Medical OfficerDec 15, 2017 Option Exercise$6.6115,11799,99430,234Dec 19, 2017, 12:23 PM
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.Dec 08, 2017 Option Exercise$1.575,1308,07919,047Dec 12, 2017, 02:35 PM
RAY DEBANJANChief Financial OfficerNov 30, 2017 Option Exercise$12.151631,98012,289Dec 05, 2017, 12:56 PM
RAY DEBANJANChief Financial OfficerDec 01, 2017 Sale$20.582,50051,4509,789Dec 05, 2017, 12:56 PM
McCarthy Sean A.President and CEONov 30, 2017 Option Exercise$12.153984,8344,643Dec 05, 2017, 12:55 PM
McCarthy Sean A.President and CEODec 01, 2017 Option Exercise$1.0814,34015,48618,983Dec 05, 2017, 12:55 PM
McCarthy Sean A.President and CEODec 01, 2017 Sale$20.6014,340295,4044,643Dec 05, 2017, 12:55 PM
McCarthy Sean A.President and CEONov 01, 2017 Option Exercise$0.9414,34213,55318,587Nov 03, 2017, 04:34 PM
McCarthy Sean A.President and CEONov 01, 2017 Sale$19.8614,342284,8324,245Nov 03, 2017, 04:34 PM
RAY DEBANJANChief Financial OfficerNov 01, 2017 Sale$20.002,50050,00012,126Nov 03, 2017, 04:33 PM
McCarthy Sean A.President and CEOOct 04, 2017 Option Exercise$0.9419,12018,06823,365Oct 06, 2017, 06:37 PM
McCarthy Sean A.President and CEOOct 04, 2017 Sale$24.1319,120461,3664,245Oct 06, 2017, 06:37 PM
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.Oct 04, 2017 Option Exercise$4.4748,368216,34062,285Oct 06, 2017, 12:20 PM
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.Oct 04, 2017 Sale$24.3448,3681,177,27713,917Oct 06, 2017, 12:20 PM
GLUCK FREDERICK WDirectorOct 04, 2017 Sale$24.2710,000242,680311,643Oct 06, 2017, 12:18 PM
McCarthy Sean A.President and CEOOct 02, 2017 Option Exercise$0.949,5629,03613,807Oct 04, 2017, 07:56 PM
McCarthy Sean A.President and CEOOct 02, 2017 Sale$18.579,562177,5664,245Oct 04, 2017, 07:56 PM
TEPPER ROBERT I10% OwnerOct 04, 2017 Sale$24.3424,777603,07229,516Oct 04, 2017, 04:09 PM
RAY DEBANJANChief Financial OfficerOct 02, 2017 Sale$18.102,50045,25014,626Oct 04, 2017, 12:38 PM
GLUCK FREDERICK WDirectorSep 26, 2017 Sale$17.305,00086,476321,643Sep 27, 2017, 04:12 PM
McCarthy Sean A.President and CEOSep 01, 2017 Option Exercise$0.949,9309,38414,175Sep 22, 2017, 02:59 PM
McCarthy Sean A.President and CEOSep 01, 2017 Sale$17.339,930172,0544,613Sep 22, 2017, 02:59 PM
McCarthy Sean A.President and CEOAug 31, 2017 Option Exercise$0.9418,75617,72423,001Sep 22, 2017, 02:58 PM
McCarthy Sean A.President and CEOAug 31, 2017 Sale$17.5018,756328,26016,439Sep 22, 2017, 02:58 PM
TEPPER ROBERT I10% OwnerSep 19, 2017 Sale$18.0020,000360,00054,293Sep 21, 2017, 04:00 PM
RAY DEBANJANChief Financial OfficerSep 01, 2017 Sale$17.172,50042,92517,126Sep 05, 2017, 06:18 PM
McCarthy Sean A.President and CEOSep 01, 2017 Option Exercise$0.949,9309,38414,175Sep 05, 2017, 06:17 PM
McCarthy Sean A.President and CEOSep 01, 2017 Sale$17.329,930171,9884,245Sep 05, 2017, 06:17 PM
McCarthy Sean A.President and CEOAug 31, 2017 Option Exercise$0.9418,75617,72423,001Sep 01, 2017, 04:28 PM
McCarthy Sean A.President and CEOAug 31, 2017 Sale$17.5018,756328,2607,245Sep 01, 2017, 04:28 PM
RAY DEBANJANChief Financial OfficerAug 09, 2017 Sale$15.002,50037,50019,626Aug 11, 2017, 12:51 PM
McCarthy Sean A.President and CEOAug 09, 2017 Option Exercise$0.944,7814,5189,026Aug 11, 2017, 12:50 PM
McCarthy Sean A.President and CEOAug 09, 2017 Sale$15.004,78171,7154,245Aug 11, 2017, 12:50 PM
McCarthy Sean A.President and CEOJul 03, 2017 Option Exercise$0.944,7814,5189,026Jul 06, 2017, 11:20 AM
McCarthy Sean A.President and CEOJul 03, 2017 Sale$15.524,78174,2014,245Jul 06, 2017, 11:20 AM
RAY DEBANJANChief Financial OfficerJul 03, 2017 Sale$15.472,50038,67522,126Jul 06, 2017, 11:20 AM
TEPPER ROBERT I10% OwnerJun 29, 2017 Sale$16.0015,000240,00044,777Jun 30, 2017, 04:00 PM
GLUCK FREDERICK WDirectorJun 26, 2017 Sale$14.615,00073,050326,643Jun 27, 2017, 04:57 PM
McCarthy Sean A.President and CEOJun 26, 2017 Option Exercise$0.944,4814,2358,726Jun 27, 2017, 04:55 PM
McCarthy Sean A.President and CEOJun 26, 2017 Sale$15.004,48167,2154,245Jun 27, 2017, 04:55 PM
McCarthy Sean A.President and CEOJun 05, 2017 Option Exercise$0.943002834,545Jun 06, 2017, 05:57 PM
McCarthy Sean A.President and CEOJun 05, 2017 Sale$15.003004,5004,245Jun 06, 2017, 05:57 PM
McCarthy Sean A.President and CEOMay 31, 2017 Option Exercise$8.682,26619,6654,245Jun 02, 2017, 03:40 PM
RAY DEBANJANChief Financial OfficerMay 31, 2017 Option Exercise$8.682,69823,41524,626Jun 02, 2017, 03:40 PM
Goeltz II Robert C.Chief Financial OfficerMay 12, 2017 Option Exercise$5.5419,967110,70032,756May 16, 2017, 04:57 PM
McCarthy Sean A.President and CEOMay 01, 2017 Option Exercise$0.944,7814,5186,760May 02, 2017, 06:11 PM
McCarthy Sean A.President and CEOMay 01, 2017 Sale$15.704,78175,0621,979May 02, 2017, 06:11 PM
STARR KEVIN P10% OwnerApr 12, 2017 Sale$16.3628,357463,79331,419Apr 14, 2017, 04:00 PM
Goeltz II Robert C.Chief Financial OfficerApr 10, 2017 Option Exercise$4.473,00013,41812,789Apr 11, 2017, 12:51 PM
McCarthy Sean A.President and CEOApr 03, 2017 Option Exercise$0.944,7814,5186,760Apr 05, 2017, 12:18 PM
McCarthy Sean A.President and CEOApr 04, 2017 Option Exercise$0.944,7814,5186,760Apr 05, 2017, 12:18 PM
McCarthy Sean A.President and CEOApr 03, 2017 Sale$16.944,78180,9901,979Apr 05, 2017, 12:18 PM
McCarthy Sean A.President and CEOApr 04, 2017 Sale$17.504,78183,6681,979Apr 05, 2017, 12:18 PM
THIRD ROCK VENTURES LP10% OwnerMar 27, 2017 Sale$18.00650,00011,700,1955,170,348Mar 27, 2017, 07:28 PM
THIRD ROCK VENTURES LP10% OwnerMar 23, 2017 Sale$17.001,000,00017,000,2005,820,348Mar 27, 2017, 07:28 PM
Goeltz II Robert C.Chief Financial OfficerMar 20, 2017 Option Exercise$4.4721,51796,24131,306Mar 21, 2017, 06:05 PM
Goeltz II Robert C.Chief Financial OfficerMar 20, 2017 Sale$19.8121,517426,34021,306Mar 21, 2017, 06:05 PM
McCarthy Sean A.President and CEOMar 20, 2017 Option Exercise$0.9414,34313,55416,322Mar 21, 2017, 06:04 PM
McCarthy Sean A.President and CEOMar 20, 2017 Sale$19.6014,343281,1231,979Mar 21, 2017, 06:04 PM
Goeltz II Robert C.Chief Financial OfficerMar 09, 2017 Option Exercise$4.472,50011,1829,789Mar 09, 2017, 07:22 PM
McCarthy Sean A.President and CEOMar 03, 2017 Option Exercise$1.1314,34316,26416,322Mar 03, 2017, 05:36 PM
McCarthy Sean A.President and CEOMar 03, 2017 Sale$15.0014,343215,1451,979Mar 03, 2017, 05:36 PM
HUMPHREY RACHELChief Medical OfficerDec 28, 2016 Option Exercise$6.6115,11799,99415,117Dec 29, 2016, 03:52 PM
McCarthy Sean A.President and CEONov 30, 2016 Option Exercise$9.101,97917,9991,979Dec 01, 2016, 07:02 PM
Goeltz II Robert C.Chief Financial OfficerNov 30, 2016 Option Exercise$9.101,28911,7237,289Dec 01, 2016, 07:01 PM
SHANNON TIMOTHY MDirectorNov 29, 2016 Sale$11.1822,086247,0083,244,381Dec 01, 2016, 02:35 PM
Canaan IX L.P.DirectorNov 29, 2016 Sale$11.1822,086247,0083,644,381Dec 01, 2016, 02:27 PM
SHANNON TIMOTHY MDirectorNov 28, 2016 Sale$11.3320,840236,1423,666,467Nov 28, 2016, 05:50 PM
SHANNON TIMOTHY MDirectorNov 25, 2016 Sale$11.796,72979,3413,687,307Nov 28, 2016, 05:50 PM
SHANNON TIMOTHY MDirectorNov 23, 2016 Sale$11.8410,890128,9213,694,036Nov 28, 2016, 05:50 PM
Canaan IX L.P.DirectorNov 25, 2016 Sale$11.796,72979,3413,687,307Nov 28, 2016, 05:10 PM
Canaan IX L.P.DirectorNov 23, 2016 Sale$11.8410,890128,9213,694,036Nov 28, 2016, 05:10 PM
Canaan IX L.P.DirectorNov 28, 2016 Sale$11.3320,840236,1423,666,467Nov 28, 2016, 05:10 PM
SHANNON TIMOTHY MDirectorNov 22, 2016 Sale$11.7142,550498,0783,704,926Nov 22, 2016, 07:01 PM
Canaan IX L.P.DirectorNov 22, 2016 Sale$11.7142,550498,0783,704,926Nov 22, 2016, 06:48 PM
SHANNON TIMOTHY MDirectorNov 17, 2016 Sale$11.5018,971218,2183,773,829Nov 21, 2016, 06:56 PM
SHANNON TIMOTHY MDirectorNov 21, 2016 Sale$11.7213,548158,7853,747,476Nov 21, 2016, 06:56 PM
SHANNON TIMOTHY MDirectorNov 18, 2016 Sale$11.6412,805149,0853,761,024Nov 21, 2016, 06:56 PM
Canaan IX L.P.DirectorNov 21, 2016 Sale$11.7213,548158,7853,747,476Nov 21, 2016, 06:48 PM
Canaan IX L.P.DirectorNov 18, 2016 Sale$11.6412,805149,0853,761,024Nov 21, 2016, 06:48 PM
Canaan IX L.P.DirectorNov 17, 2016 Sale$11.5018,971218,2183,773,829Nov 21, 2016, 06:48 PM
SHANNON TIMOTHY MDirectorNov 16, 2016 Sale$11.5518,517213,9533,792,800Nov 16, 2016, 07:33 PM
SHANNON TIMOTHY MDirectorNov 15, 2016 Sale$11.4833,064379,4763,811,317Nov 16, 2016, 07:33 PM
Canaan IX L.P.DirectorNov 15, 2016 Sale$11.4833,064379,4763,811,317Nov 16, 2016, 07:13 PM
Canaan IX L.P.DirectorNov 16, 2016 Sale$11.5518,517213,9533,792,800Nov 16, 2016, 07:13 PM
SHANNON TIMOTHY MDirectorNov 10, 2016 Sale$11.0727,135300,3903,903,516Nov 14, 2016, 05:41 PM
SHANNON TIMOTHY MDirectorNov 14, 2016 Sale$11.2123,744266,0563,844,381Nov 14, 2016, 05:41 PM
SHANNON TIMOTHY MDirectorNov 11, 2016 Sale$11.2035,391396,4613,868,125Nov 14, 2016, 05:41 PM
Canaan IX L.P.DirectorNov 14, 2016 Sale$11.2123,744266,0563,844,381Nov 14, 2016, 04:41 PM
Canaan IX L.P.DirectorNov 11, 2016 Sale$11.2035,391396,4613,868,125Nov 14, 2016, 04:41 PM
Canaan IX L.P.DirectorNov 10, 2016 Sale$11.0727,135300,3903,903,516Nov 14, 2016, 04:41 PM
SHANNON TIMOTHY MDirectorNov 09, 2016 Sale$11.0313,730151,4983,930,651Nov 10, 2016, 04:41 PM
Canaan IX L.P.DirectorNov 09, 2016 Sale$11.0313,730151,4983,930,651Nov 10, 2016, 04:36 PM
Goeltz II Robert C.Chief Financial OfficerSep 29, 2016 Option Exercise$4.474,00017,8916,000Oct 03, 2016, 02:32 PM
GLUCK FREDERICK WDirectorAug 09, 2016 Option Exercise$1.2793,124118,709240,915Aug 11, 2016, 12:29 PM
SHANNON TIMOTHY MDirectorJun 08, 2016 Sale$10.0822,885230,6814,269,923Jun 10, 2016, 06:21 PM
SHANNON TIMOTHY MDirectorJun 10, 2016 Sale$10.012,70027,0274,244,381Jun 10, 2016, 06:21 PM
SHANNON TIMOTHY MDirectorJun 09, 2016 Sale$10.0622,842229,7914,247,081Jun 10, 2016, 06:21 PM
Canaan IX L.P.DirectorJun 10, 2016 Sale$10.012,70027,0274,244,381Jun 10, 2016, 04:13 PM
Canaan IX L.P.DirectorJun 09, 2016 Sale$10.0622,842229,7914,247,081Jun 10, 2016, 04:13 PM
Canaan IX L.P.DirectorJun 08, 2016 Sale$10.0822,885230,6814,269,923Jun 10, 2016, 04:13 PM
SHANNON TIMOTHY MDirectorJun 07, 2016 Sale$10.039,73197,6024,292,808Jun 08, 2016, 07:32 PM
SHANNON TIMOTHY MDirectorJun 06, 2016 Sale$10.01101,7671,018,6884,302,539Jun 08, 2016, 07:32 PM
Canaan IX L.P.DirectorJun 07, 2016 Sale$10.039,73197,6024,292,808Jun 08, 2016, 07:22 PM
Canaan IX L.P.DirectorJun 06, 2016 Sale$10.01101,7671,018,6884,302,539Jun 08, 2016, 07:22 PM
SHANNON TIMOTHY MDirectorJun 03, 2016 Sale$10.8318,428199,5754,404,306Jun 06, 2016, 04:18 PM
SHANNON TIMOTHY MDirectorJun 02, 2016 Sale$10.7941,193444,4724,422,734Jun 06, 2016, 04:18 PM
Canaan IX L.P.DirectorJun 03, 2016 Sale$10.8318,428199,5754,404,306Jun 06, 2016, 04:10 PM
Canaan IX L.P.DirectorJun 02, 2016 Sale$10.7941,193444,4724,422,734Jun 06, 2016, 04:10 PM
SHANNON TIMOTHY MDirectorJun 01, 2016 Sale$10.7522,463241,4774,463,927Jun 02, 2016, 04:17 PM
Canaan IX L.P.DirectorJun 01, 2016 Sale$10.7522,463241,4774,463,927Jun 02, 2016, 04:10 PM
SHANNON TIMOTHY MDirectorMay 27, 2016 Sale$10.6025,082265,8694,486,390Jun 01, 2016, 04:18 PM
Canaan IX L.P.DirectorMay 27, 2016 Sale$10.6025,082265,8694,486,390Jun 01, 2016, 04:10 PM
SHANNON TIMOTHY MDirectorMay 25, 2016 Sale$10.0211,456114,7894,551,359May 27, 2016, 04:21 PM
SHANNON TIMOTHY MDirectorMay 26, 2016 Sale$10.4339,887416,0214,511,472May 27, 2016, 04:21 PM
Canaan IX L.P.DirectorMay 26, 2016 Sale$10.4339,887416,0214,511,472May 27, 2016, 04:11 PM
Canaan IX L.P.DirectorMay 25, 2016 Sale$10.0211,456114,7894,551,359May 27, 2016, 04:11 PM
SHANNON TIMOTHY MDirectorMay 24, 2016 Sale$10.001,20012,0004,562,815May 25, 2016, 04:27 PM
SHANNON TIMOTHY MDirectorMay 23, 2016 Sale$10.1012,053121,7354,564,015May 25, 2016, 04:27 PM
Canaan IX L.P.DirectorMay 24, 2016 Sale$10.001,20012,0004,562,815May 25, 2016, 04:10 PM
Canaan IX L.P.DirectorMay 23, 2016 Sale$10.1012,053121,7354,564,015May 25, 2016, 04:10 PM
SHANNON TIMOTHY MDirectorMay 19, 2016 Sale$10.142,50025,3504,582,255May 23, 2016, 06:02 PM
SHANNON TIMOTHY MDirectorMay 20, 2016 Sale$10.096,18762,4274,576,068May 23, 2016, 06:02 PM
Canaan IX L.P.DirectorMay 20, 2016 Sale$10.096,18762,4274,576,068May 23, 2016, 05:01 PM
Canaan IX L.P.DirectorMay 19, 2016 Sale$10.142,50025,3504,582,255May 23, 2016, 05:01 PM
Goeltz II Robert C.May 12, 2016 Option Exercise$4.472,0008,9462,000May 13, 2016, 04:05 PM
Kavanaugh William MichaelChief Scientific Officer andDec 31, 2015 Option Exercise$6.618,91758,98313,917Dec 31, 2015, 01:01 PM
LADD CYNTHIA JSenior VP and General CounselOct 14, 2015 Buy$12.003,00036,0003,000Oct 16, 2015, 10:19 AM
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.Oct 14, 2015 Buy$12.005,00060,0005,000Oct 16, 2015, 10:17 AM
GLUCK FREDERICK WDirectorOct 14, 2015 Buy$12.005,00060,0005,000Oct 16, 2015, 10:15 AM
GLUCK FREDERICK WDirectorOct 14, 2015 Buy$12.0010,000120,000147,791Oct 16, 2015, 10:15 AM
Flynn James E10% OwnerOct 14, 2015 Buy$12.00114,4881,373,856275,000Oct 14, 2015, 12:34 PM
Flynn James E10% OwnerOct 14, 2015 Buy$12.00510,5126,126,144671,024Oct 14, 2015, 12:34 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
McCarthy Sean A.CEO03/26/2024172,874
ROWLAND LLOYD AGeneral Counsel03/19/202410,986
McCarthy Sean A.CEO03/19/202442,175
Ogden ChristopherSVP, Finance and Accounting03/19/20246,196
BELVIN MARCIASVP, Chief Scientific Officer03/19/202426,684
Landau Jeffrey BChief Business Officer03/19/202413,685
McCarthy Sean A.CEO12/20/202318,710
BELVIN MARCIASVP, Chief Scientific Officer12/20/20235,628
Landau Jeffrey BChief Business Officer12/20/20235,628
ROWLAND LLOYD AGeneral Counsel12/20/20235,629
Ogden ChristopherSVP, Finance and Accounting12/20/20232,747
BELVIN MARCIASVP, Chief Scientific Officer09/22/20235,356
Landau Jeffrey BChief Business Officer09/22/20235,356
McCarthy Sean A.CEO09/22/202318,987
ROWLAND LLOYD AGeneral Counsel09/22/20237,135
McCarthy Sean A.CEO05/19/202326,041
Jones Elaine VDirector03/29/20237,750
Ogden ChristopherSVP, Finance and Accounting03/16/20231,021
McCarthy Sean A.CEO03/16/202313,391
Campoy CarlosChief Financial Officer03/16/20233,459
ROWLAND LLOYD AGeneral Counsel03/16/20234,031
Landau Jeffrey BChief Financial Officer03/16/20232,923
Peterson Amy C.EVP, Chief Development Officer03/16/20238,425
Peterson Amy C.EVP, Chief Development Officer07/20/202210,612
Landau Jeffrey BChief Business Officer07/20/20225,982
McCarthy Sean A.President and CEO07/20/202221,206
ROWLAND LLOYD AGeneral Counsel07/20/20227,968
HANNAH ALISON L.Chief Medical Officer07/20/20227,965
Campoy CarlosChief Financial Officer07/20/20225,617
McCarthy Sean A.President and CEO05/09/202285,930
McCarthy Sean A.President and CEO08/11/2021104,447
McCarthy Sean A.President and CEO06/14/202143
Campoy CarlosChief Financial Officer05/31/202120,206
Peterson Amy C.EVP, Chief Development Officer05/31/202120,206
McCarthy Sean A.President and CEO12/23/2020113,390
Peterson Amy C.EVP, Chief Development Officer11/30/202019,822
McCarthy Sean A.President and CEO11/30/20205,945
Campoy CarlosChief Financial Officer11/30/202019,822
McCarthy Sean A.President and CEO09/21/2020135,601
McCarthy Sean A.President and CEO05/29/20205,916
McCarthy Sean A.President and CEO05/12/202040,820
McCarthy Sean A.President and CEO05/12/2020540,000
McCarthy Sean A.President and CEO11/30/20195,747
ROWLAND LLOYD AGeneral Counsel05/31/201914,878
Knifsend RobinPrincipal Accounting Officer05/31/201914,878
McCarthy Sean A.President and CEO05/31/20195,707
ROWLAND LLOYD AGeneral Counsel03/04/201992,970
RAY DEBANJANChief Financial Officer12/12/20184,347
RAY DEBANJANChief Financial Officer12/12/201845,000
McCarthy Sean A.President and CEO11/30/20185,490
ROWLAND LLOYD AGeneral Counsel11/30/201811,484
RAY DEBANJANChief Financial Officer11/01/20184,347
RAY DEBANJANChief Financial Officer11/01/201845,000
McCarthy Sean A.President and CEO11/02/20181,821
McCarthy Sean A.President and CEO11/01/20188,457
McCarthy Sean A.President and CEO11/02/201817,348
McCarthy Sean A.President and CEO11/01/201880,551
RAY DEBANJANChief Financial Officer10/01/20184,347
RAY DEBANJANChief Financial Officer10/01/201855,380
RAY DEBANJANChief Financial Officer09/04/20184,347
RAY DEBANJANChief Financial Officer09/04/201867,170
McCarthy Sean A.President and CEO09/04/201820,556
McCarthy Sean A.President and CEO09/04/2018285,343
RAY DEBANJANChief Financial Officer08/01/20183,835
RAY DEBANJANChief Financial Officer08/01/201878,150
McCarthy Sean A.President and CEO07/05/20187,082
McCarthy Sean A.President and CEO07/05/2018112,689
McCarthy Sean A.President and CEO07/03/20183,194
McCarthy Sean A.President and CEO07/03/201850,880
RAY DEBANJANChief Financial Officer07/02/20183,780
RAY DEBANJANChief Financial Officer07/02/201867,680
McCarthy Sean A.President and CEO07/02/201820,556
McCarthy Sean A.President and CEO07/02/2018305,708
RAY DEBANJANChief Financial Officer05/31/201821,248
RAY DEBANJANChief Financial Officer06/01/20183,780
RAY DEBANJANChief Financial Officer06/01/201877,793
McCarthy Sean A.President and CEO05/31/20185,406
RAY DEBANJANChief Financial Officer05/01/20183,780
RAY DEBANJANChief Financial Officer05/01/201879,562
McCarthy Sean A.President and CEO05/01/201830,833
McCarthy Sean A.President and CEO05/01/2018519,743
RAY DEBANJANChief Financial Officer04/02/20183,780
RAY DEBANJANChief Financial Officer04/02/201884,360
GLUCK FREDERICK WDirector03/26/2018159,642
GLUCK FREDERICK WDirector03/02/2018485,466
HUMPHREY RACHELChief Medical Officer03/02/2018106,894
HUMPHREY RACHELChief Medical Officer03/02/2018484,800
McCarthy Sean A.President and CEO03/01/201826,825
RAY DEBANJANChief Financial Officer03/02/201823,373
RAY DEBANJANChief Financial Officer03/01/201816,379
McCarthy Sean A.President and CEO03/01/2018576,141
RAY DEBANJANChief Financial Officer03/02/2018607,453
RAY DEBANJANChief Financial Officer03/01/2018382,242
HUMPHREY RACHELChief Medical Officer02/28/2018157,694
HUMPHREY RACHELChief Medical Officer02/28/2018715,200
GLUCK FREDERICK WDirector02/28/2018114,570
RAY DEBANJANChief Financial Officer02/01/201868,010
McCarthy Sean A.President and CEO01/05/20187,400
McCarthy Sean A.President and CEO01/05/2018163,215
GLUCK FREDERICK WDirector01/05/2018250,078
McCarthy Sean A.President and CEO01/02/201814,800
McCarthy Sean A.President and CEO01/02/2018274,614
RAY DEBANJANChief Financial Officer01/02/201852,775
GLUCK FREDERICK WDirector12/26/2017111,426
HUMPHREY RACHELChief Medical Officer12/15/201799,994
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.12/08/20178,079
RAY DEBANJANChief Financial Officer11/30/20171,980
RAY DEBANJANChief Financial Officer12/01/201751,450
McCarthy Sean A.President and CEO11/30/20174,834
McCarthy Sean A.President and CEO12/01/201715,486
McCarthy Sean A.President and CEO12/01/2017295,404
McCarthy Sean A.President and CEO11/01/201713,553
McCarthy Sean A.President and CEO11/01/2017284,832
RAY DEBANJANChief Financial Officer11/01/201750,000
McCarthy Sean A.President and CEO10/04/201718,068
McCarthy Sean A.President and CEO10/04/2017461,366
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.10/04/2017216,340
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.10/04/20171,177,277
GLUCK FREDERICK WDirector10/04/2017242,680
McCarthy Sean A.President and CEO10/02/20179,036
McCarthy Sean A.President and CEO10/02/2017177,566
TEPPER ROBERT I10% Owner10/04/2017603,072
RAY DEBANJANChief Financial Officer10/02/201745,250
GLUCK FREDERICK WDirector09/26/201786,476
McCarthy Sean A.President and CEO09/01/20179,384
McCarthy Sean A.President and CEO09/01/2017172,054
McCarthy Sean A.President and CEO08/31/201717,724
McCarthy Sean A.President and CEO08/31/2017328,260
TEPPER ROBERT I10% Owner09/19/2017360,000
RAY DEBANJANChief Financial Officer09/01/201742,925
McCarthy Sean A.President and CEO09/01/20179,384
McCarthy Sean A.President and CEO09/01/2017171,988
McCarthy Sean A.President and CEO08/31/201717,724
McCarthy Sean A.President and CEO08/31/2017328,260
RAY DEBANJANChief Financial Officer08/09/201737,500
McCarthy Sean A.President and CEO08/09/20174,518
McCarthy Sean A.President and CEO08/09/201771,715
McCarthy Sean A.President and CEO07/03/20174,518
McCarthy Sean A.President and CEO07/03/201774,201
RAY DEBANJANChief Financial Officer07/03/201738,675
TEPPER ROBERT I10% Owner06/29/2017240,000
GLUCK FREDERICK WDirector06/26/201773,050
McCarthy Sean A.President and CEO06/26/20174,235
McCarthy Sean A.President and CEO06/26/201767,215
McCarthy Sean A.President and CEO06/05/2017283
McCarthy Sean A.President and CEO06/05/20174,500
McCarthy Sean A.President and CEO05/31/201719,665
RAY DEBANJANChief Financial Officer05/31/201723,415
Goeltz II Robert C.Chief Financial Officer05/12/2017110,700
McCarthy Sean A.President and CEO05/01/20174,518
McCarthy Sean A.President and CEO05/01/201775,062
STARR KEVIN P10% Owner04/12/2017463,793
Goeltz II Robert C.Chief Financial Officer04/10/201713,418
McCarthy Sean A.President and CEO04/03/20174,518
McCarthy Sean A.President and CEO04/04/20174,518
McCarthy Sean A.President and CEO04/03/201780,990
McCarthy Sean A.President and CEO04/04/201783,668
THIRD ROCK VENTURES LP10% Owner03/27/201711,700,195
THIRD ROCK VENTURES LP10% Owner03/23/201717,000,200
Goeltz II Robert C.Chief Financial Officer03/20/201796,241
Goeltz II Robert C.Chief Financial Officer03/20/2017426,340
McCarthy Sean A.President and CEO03/20/201713,554
McCarthy Sean A.President and CEO03/20/2017281,123
Goeltz II Robert C.Chief Financial Officer03/09/201711,182
McCarthy Sean A.President and CEO03/03/201716,264
McCarthy Sean A.President and CEO03/03/2017215,145
HUMPHREY RACHELChief Medical Officer12/28/201699,994
McCarthy Sean A.President and CEO11/30/201617,999
Goeltz II Robert C.Chief Financial Officer11/30/201611,723
SHANNON TIMOTHY MDirector11/29/2016247,008
Canaan IX L.P.Director11/29/2016247,008
SHANNON TIMOTHY MDirector11/28/2016236,142
SHANNON TIMOTHY MDirector11/25/201679,341
SHANNON TIMOTHY MDirector11/23/2016128,921
Canaan IX L.P.Director11/25/201679,341
Canaan IX L.P.Director11/23/2016128,921
Canaan IX L.P.Director11/28/2016236,142
SHANNON TIMOTHY MDirector11/22/2016498,078
Canaan IX L.P.Director11/22/2016498,078
SHANNON TIMOTHY MDirector11/17/2016218,218
SHANNON TIMOTHY MDirector11/21/2016158,785
SHANNON TIMOTHY MDirector11/18/2016149,085
Canaan IX L.P.Director11/21/2016158,785
Canaan IX L.P.Director11/18/2016149,085
Canaan IX L.P.Director11/17/2016218,218
SHANNON TIMOTHY MDirector11/16/2016213,953
SHANNON TIMOTHY MDirector11/15/2016379,476
Canaan IX L.P.Director11/15/2016379,476
Canaan IX L.P.Director11/16/2016213,953
SHANNON TIMOTHY MDirector11/10/2016300,390
SHANNON TIMOTHY MDirector11/14/2016266,056
SHANNON TIMOTHY MDirector11/11/2016396,461
Canaan IX L.P.Director11/14/2016266,056
Canaan IX L.P.Director11/11/2016396,461
Canaan IX L.P.Director11/10/2016300,390
SHANNON TIMOTHY MDirector11/09/2016151,498
Canaan IX L.P.Director11/09/2016151,498
Goeltz II Robert C.Chief Financial Officer09/29/201617,891
GLUCK FREDERICK WDirector08/09/2016118,709
SHANNON TIMOTHY MDirector06/08/2016230,681
SHANNON TIMOTHY MDirector06/10/201627,027
SHANNON TIMOTHY MDirector06/09/2016229,791
Canaan IX L.P.Director06/10/201627,027
Canaan IX L.P.Director06/09/2016229,791
Canaan IX L.P.Director06/08/2016230,681
SHANNON TIMOTHY MDirector06/07/201697,602
SHANNON TIMOTHY MDirector06/06/20161,018,688
Canaan IX L.P.Director06/07/201697,602
Canaan IX L.P.Director06/06/20161,018,688
SHANNON TIMOTHY MDirector06/03/2016199,575
SHANNON TIMOTHY MDirector06/02/2016444,472
Canaan IX L.P.Director06/03/2016199,575
Canaan IX L.P.Director06/02/2016444,472
SHANNON TIMOTHY MDirector06/01/2016241,477
Canaan IX L.P.Director06/01/2016241,477
SHANNON TIMOTHY MDirector05/27/2016265,869
Canaan IX L.P.Director05/27/2016265,869
SHANNON TIMOTHY MDirector05/25/2016114,789
SHANNON TIMOTHY MDirector05/26/2016416,021
Canaan IX L.P.Director05/26/2016416,021
Canaan IX L.P.Director05/25/2016114,789
SHANNON TIMOTHY MDirector05/24/201612,000
SHANNON TIMOTHY MDirector05/23/2016121,735
Canaan IX L.P.Director05/24/201612,000
Canaan IX L.P.Director05/23/2016121,735
SHANNON TIMOTHY MDirector05/19/201625,350
SHANNON TIMOTHY MDirector05/20/201662,427
Canaan IX L.P.Director05/20/201662,427
Canaan IX L.P.Director05/19/201625,350
Goeltz II Robert C.05/12/20168,946
Kavanaugh William MichaelChief Scientific Officer and12/31/201558,983
LADD CYNTHIA JSenior VP and General Counsel10/14/201536,000
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.10/14/201560,000
GLUCK FREDERICK WDirector10/14/201560,000
GLUCK FREDERICK WDirector10/14/2015120,000
Flynn James E10% Owner10/14/20151,373,856
Flynn James E10% Owner10/14/20156,126,144
Load More Insider Transactions
FUNDS WITH A POSITION IN CYTOMX THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC1,325,7000.00318%42.53%Other
BLACKROCK INC.1,136,1350.00004%-0.31%Other
GEODE CAPITAL MANAGEMENT, LLC702,6540.00011%3.89%Other
TUDOR INVESTMENT CORP ET AL44,7300.00056%No changeEvent Driven, Other
D. E. SHAW & CO., INC.11,5770.00002%-84.25%Other
CHANGE IN SHARES OUTSTANDING FOR CYTOMX THERAPEUTICS INC
STOCK BUYBACKS FOR CYTOMX THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.70%
1Q
12/31/2023
06/30/2023
22.57%
2Q
12/31/2023
03/31/2023
23.11%
3Q
12/31/2023
12/31/2022
23.37%
4Q
12/31/2023
09/30/2022
23.74%
5Q
12/31/2023
06/30/2022
24.43%
6Q
12/31/2023
03/31/2022
24.72%
7Q
12/31/2023
12/31/2021
24.88%
8Q
12/31/2023
09/30/2021
25.07%
9Q
12/31/2023
06/30/2021
25.36%
10Q
12/31/2023
03/31/2021
33.77%
11Q
12/31/2023
12/31/2020
75.00%
12Q
12/31/2023
09/30/2020
76.55%
13Q
12/31/2023
06/30/2020
77.08%
14Q
12/31/2023
03/31/2020
73.36%
15Q
12/31/2023
12/31/2019
79.40%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.70%
1Q
06/30/2023
22.57%
2Q
03/31/2023
23.11%
3Q
12/31/2022
23.37%
4Q
09/30/2022
23.74%
5Q
06/30/2022
24.43%
6Q
03/31/2022
24.72%
7Q
12/31/2021
24.88%
8Q
09/30/2021
25.07%
9Q
06/30/2021
25.36%
10Q
03/31/2021
33.77%
11Q
12/31/2020
75.00%
12Q
09/30/2020
76.55%
13Q
06/30/2020
77.08%
14Q
03/31/2020
73.36%
15Q
12/31/2019
79.40%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CYTOMX THERAPEUTICS INC
LOADING...